
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
ICS Global Limited is a health information services business based in Australia. ICS Global shares (ICS) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. ICS Global has a trailing 12-month revenue of around $6.1 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $1.4 - $2.45 |
---|---|
50-day moving average | $1.8242 |
200-day moving average | $1.812 |
Target price | N/A |
PE ratio | 14.7639 |
Dividend yield | $0.09 (5.23%) |
Earnings per share (TTM) | $0.116 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$1.8 on 2020-10-22
1 week (2021-01-14) | -14.69% |
---|---|
1 month (2020-12-21) | -12.20% |
3 months (2020-10-21) | 3.15% |
6 months (2020-07-21) | 5.88% |
1 year (2020-01-21) | -5.51% |
---|---|
2 years (2019-01-21) | 95.65% |
3 years (2018-01-19) | 30.43% |
5 years (2016-01-21) | 20.00% |
Valuing ICS Global stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICS Global 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ICS Global 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, ICS Global shares trade at around 15x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
ICS Global 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 million (£755,838).
The EBITDA is a measure of a ICS Global 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $6.1 million |
---|---|
Operating margin TTM | 20.53% |
Gross profit TTM | $3.2 million |
Return on assets TTM | 8.85% |
Return on equity TTM | 19.84% |
Profit margin | 20.27% |
Book value | 0.594 |
Market capitalisation | $17.9 million |
TTM: trailing 12 months
Dividend payout ratio: 112.5% of net profits
Recently ICS Global has paid out, on average, around 112.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ICS Global shareholders could enjoy a 5.23% return on their shares, in the form of dividend payments. In ICS Global 's case, that would currently equate to about A$0.09 per share.
ICS Global 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 October 2020 (the "ex-dividend date").
ICS Global 's shares were split on a 1:20 basis on 24 November 2014. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ICS Global shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ICS Global shares which in turn could have impacted ICS Global 's share price.
Over the last 12 months, ICS Global 's shares have ranged in value from as little as $1.4 up to $2.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while ICS Global 's is 1.0191. This would suggest that ICS Global 's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
ICS Global Limited, an investment holding company, provides medical billing services primarily in the United Kingdom. The company offers medical billing and collection services to medical consultants and specialists. The company was founded in 1999 and is based in Sydney, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.